Memcad 0.2mg Injection
Marketer
Zydus Cadila
Salt Composition
Methylergometrine (0.2mg)
Overview Memcad 0.2mg Injection
Uterine bleeding following childbirth or termination of pregnancy may be managed with a 0.2mg injection of Memcad. This medication acts on uterine smooth muscle, enhancing contractility (tone, rate, and amplitude) to minimize blood loss. Administration is strictly by a physician in a hospital setting via intravenous or intramuscular injection; self-administration is prohibited. Dosage and frequency are determined by your physician based on your individual needs and condition, aiming to alleviate symptoms. Common adverse effects include headache, elevated blood pressure, and convulsions. Report any concerning or severe side effects immediately to your doctor; management strategies may be available. Alcohol consumption is generally discouraged during treatment. Prior to commencing therapy, inform your physician of any pre-existing heart conditions or hypertension, as well as all other medications you are currently using, as interactions may affect Memcad's efficacy or mechanism of action.
Uses of Memcad 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Memcad 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Memcad 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Memcad 0.2mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Memcad 0.2mg Injection works:
Ergot alkaloid injection Memcad (0.2mg) induces prolonged uterine smooth muscle contractions. This vascular constriction effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Memcad 0.2mg Injection may be unsafe; physician consultation is advised.
PregnancyUNSAFE
Administering Memcad 0.2mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in animal and human studies reveals considerable adverse effects on fetal development.
Breast feedingCAUTION
Administering Memcad 0.2mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingCONSULT YOUR DOCTOR
The effect of Memcad 0.2mg Injection on driving ability is unknown. Refrain from driving if you experience any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Memcad 0.2mg Injection in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Memcad 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Memcad 0.2mg Injection :
NA
Facts to Know About Memcad 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Action Class | Drugs that induce uterine contractions and/or abortion |
3,018 People bought this recently